| Product NDC: | 42291-845 |
| Proprietary Name: | Trimethoprim |
| Non Proprietary Name: | trimethoprim |
| Active Ingredient(s): | 100 mg/1 & nbsp; trimethoprim |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 42291-845 |
| Labeler Name: | AvKARE, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091437 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130506 |
| Package NDC: | 42291-845-90 |
| Package Description: | 90 TABLET in 1 BOTTLE (42291-845-90) |
| NDC Code | 42291-845-90 |
| Proprietary Name | Trimethoprim |
| Package Description | 90 TABLET in 1 BOTTLE (42291-845-90) |
| Product NDC | 42291-845 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | trimethoprim |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20130506 |
| Marketing Category Name | ANDA |
| Labeler Name | AvKARE, Inc. |
| Substance Name | TRIMETHOPRIM |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Dihydrofolate Reductase Inhibitor Antibacterial [EPC],Dihydrofolate Reductase Inhibitors [MoA] |